Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Beyond Dysplasia Grade: The Role of Biomarkers in Stratifying Risk.

Dunbar KB, Souza RF.

Gastrointest Endosc Clin N Am. 2017 Jul;27(3):447-459. doi: 10.1016/j.giec.2017.02.003. Review.

PMID:
28577766
2.

GalNAc-T6 in the relationship with invasion ability of endometrial carcinomas and prognostic significance.

Nguyen TT, Kurita T, Koi C, Murakami M, Kagami S, Hachisuga T, Masanori H, Morimoto Y, Izumi H.

Am J Cancer Res. 2017 May 1;7(5):1188-1197. eCollection 2017.

3.

Biological functions of fucose in mammals.

Schneider M, Al-Shareffi E, Haltiwanger RS.

Glycobiology. 2017 Jul 1;27(7):601-618. doi: 10.1093/glycob/cwx034.

PMID:
28430973
4.

HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma.

Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K.

Sci Rep. 2017 Mar 31;7:45768. doi: 10.1038/srep45768.

5.

Unlocking Cancer Glycomes from Histopathological Formalin-fixed and Paraffin-embedded (FFPE) Tissue Microdissections.

Hinneburg H, Korać P, Schirmeister F, Gasparov S, Seeberger PH, Zoldoš V, Kolarich D.

Mol Cell Proteomics. 2017 Apr;16(4):524-536. doi: 10.1074/mcp.M116.062414. Epub 2017 Jan 25.

PMID:
28122943
6.

Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase.

Nikolovska K, Spillmann D, Haier J, Ladányi A, Stock C, Seidler DG.

PLoS One. 2017 Jan 20;12(1):e0170054. doi: 10.1371/journal.pone.0170054. eCollection 2017.

7.

Glycan Alteration Imparts Cellular Resistance to a Membrane-Lytic Anticancer Peptide.

Ishikawa K, Medina SH, Schneider JP, Klar AJ.

Cell Chem Biol. 2017 Feb 16;24(2):149-158. doi: 10.1016/j.chembiol.2016.12.009. Epub 2017 Jan 12.

PMID:
28089756
8.

Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer.

Kim JH, Lee SH, Choi S, Kim U, Yeo IS, Kim SH, Oh MJ, Moon H, Lee J, Jeong S, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Min YW, Lee H, Lee JH, Rhee PL, Kim JJ, Lee SJ, Kim ST, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK, An HJ, Kim JH.

Oncotarget. 2017 Feb 14;8(7):11094-11104. doi: 10.18632/oncotarget.14362.

9.

Cancer Therapy Due to Apoptosis: Galectin-9.

Fujita K, Iwama H, Oura K, Tadokoro T, Samukawa E, Sakamoto T, Nomura T, Tani J, Yoneyama H, Morishita A, Himoto T, Hirashima M, Masaki T.

Int J Mol Sci. 2017 Jan 1;18(1). pii: E74. doi: 10.3390/ijms18010074. Review.

10.

Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma.

Fan B, Kang L, Chen L, Sun P, Jin M, Wang Q, Bae YH, Huang W, Gao Z.

Theranostics. 2017 Jan 1;7(2):357-376. doi: 10.7150/thno.16855. eCollection 2017.

11.

Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.

Badr HA, AlSadek DM, El-Houseini ME, Saeui CT, Mathew MP, Yarema KJ, Ahmed H.

Biomaterials. 2017 Feb;116:158-173. doi: 10.1016/j.biomaterials.2016.11.044. Epub 2016 Nov 25. Review.

PMID:
27926828
12.

Effects of Glycosylation on the Enzymatic Activity and Mechanisms of Proteases.

Goettig P.

Int J Mol Sci. 2016 Nov 25;17(12). pii: E1969. Review.

13.

A network-based phenotype mapping approach to identify genes that modulate drug response phenotypes.

Cairns J, Ung CY, da Rocha EL, Zhang C, Correia C, Weinshilboum R, Wang L, Li H.

Sci Rep. 2016 Nov 14;6:37003. doi: 10.1038/srep37003.

14.

Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.

Ho WL, Hsu WM, Huang MC, Kadomatsu K, Nakagawara A.

J Hematol Oncol. 2016 Sep 29;9(1):100. Review.

15.

Designing sugar mimetics: non-natural pyranosides as innovative chemical tools.

Saliba RC, Pohl NL.

Curr Opin Chem Biol. 2016 Oct;34:127-134. doi: 10.1016/j.cbpa.2016.08.027. Epub 2016 Sep 10. Review.

PMID:
27621102
16.

Precision glycocalyx editing as a strategy for cancer immunotherapy.

Xiao H, Woods EC, Vukojicic P, Bertozzi CR.

Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10304-9. doi: 10.1073/pnas.1608069113. Epub 2016 Aug 22.

17.

Different expression levels of glycans on leukemic cells-a novel screening method with molecularly imprinted polymers (MIP) targeting sialic acid.

El-Schich Z, Abdullah M, Shinde S, Dizeyi N, Rosén A, Sellergren B, Wingren AG.

Tumour Biol. 2016 Oct;37(10):13763-13768. Epub 2016 Jul 31.

18.

A systematic framework to derive N-glycan biosynthesis process and the automated construction of glycosylation networks.

Hou W, Qiu Y, Hashimoto N, Ching WK, Aoki-Kinoshita KF.

BMC Bioinformatics. 2016 Jul 25;17 Suppl 7:240. doi: 10.1186/s12859-016-1094-6.

19.

Efficient and Regioselective Synthesis of β-GalNAc/GlcNAc-Lactose by a Bifunctional Transglycosylating β-N-Acetylhexosaminidase from Bifidobacterium bifidum.

Chen X, Xu L, Jin L, Sun B, Gu G, Lu L, Xiao M.

Appl Environ Microbiol. 2016 Aug 30;82(18):5642-52. doi: 10.1128/AEM.01325-16. Print 2016 Sep 15.

20.

Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Yingchoncharoen P, Kalinowski DS, Richardson DR.

Pharmacol Rev. 2016 Jul;68(3):701-87. doi: 10.1124/pr.115.012070. Review.

Supplemental Content

Support Center